In cardiovascular diseases, RhoGEFs such as ARHGEF1 and LARG contribute to hypertension and aneurysm formation through activation of the Ang II‐induced RhoA/ROCK pathway, leading to endothelial dysfunction. The gene discussed is RHOA; the disease is Hypertension.